{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:41:52Z","timestamp":1791283312278,"version":"4.1.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1097\/01.hjh.0000251908.93298.a0","type":"journal-article","created":{"date-parts":[[2006,11,2]],"date-time":"2006-11-02T15:51:17Z","timestamp":1162482677000},"page":"2459-2464","source":"Crossref","is-referenced-by-count":27,"title":["QT interval in patients with primary aldosteronism and low-renin essential hypertension"],"prefix":"10.1097","volume":"24","author":[{"given":"Simona","family":"Maule","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Mulatero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Milan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giannina","family":"Leotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mimma","family":"Caserta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Bertello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Rabbia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Veglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-22-20210208","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R2-22-20210208","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(97)05189-1","article-title":"Sodium sensitivity and cardiovascular events in patients with essential hypertension","volume":"350","author":"Morimoto","year":"1997","journal-title":"Lancet"},{"key":"R3-22-20210208","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1161\/01.HYP.37.2.429","article-title":"Salt sensitivity, pulse pressure, and death in normal and hypertensive humans","volume":"37","author":"Weinberger","year":"2001","journal-title":"Hypertension"},{"key":"R4-22-20210208","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"R5-22-20210208","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"R6-22-20210208","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1161\/01.CIR.84.4.1516","article-title":"QT interval prolongation predicts cardiovascular mortality in an apparently healthy population","volume":"84","author":"Schouten","year":"1991","journal-title":"Circulation"},{"key":"R7-22-20210208","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF00400416","article-title":"Prolonged QT interval as a predictor of mortality in diabetic nephropathy","volume":"39","author":"Sawicki","year":"1996","journal-title":"Diabetologia"},{"key":"R8-22-20210208","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1161\/01.CIR.57.6.1074","article-title":"QT interval prolongation as a predictor of sudden death in patients with myocardial infarction","volume":"57","author":"Schwartz","year":"1978","journal-title":"Circulation"},{"key":"R9-22-20210208","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/hrt.71.3.268","article-title":"QT interval dispersion in chronic heart failure and left ventricular hypertrophy: relation to autonomic nervous system and Holter tape abnormalities","volume":"71","author":"Davey","year":"1994","journal-title":"Br Heart J"},{"key":"R10-22-20210208","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.tem.2005.02.007","article-title":"Diagnosis of primary aldosteronism: from screening to subtype differentiation","volume":"16","author":"Mulatero","year":"2005","journal-title":"Trends Endocrinol Metab"},{"key":"R11-22-20210208","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jc.2003-031337","article-title":"Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents","volume":"89","author":"Mulatero","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R12-22-20210208","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/01.HYP.6.5.717","article-title":"Further evaluation of saline infusion for the diagnosis of primary aldosteronism","volume":"6","author":"Holland","year":"1984","journal-title":"Hypertension"},{"key":"R13-22-20210208","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0735-1097(84)80141-2","article-title":"Standardization of M-mode echocardiographic left ventricular anatomic measurements","volume":"4","author":"Devereux","year":"1984","journal-title":"J Am Coll Cardiol"},{"key":"R14-22-20210208","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","article-title":"Statistical methods for assessing agreement between two methods of clinical measurement","volume":"8","author":"Bland","year":"1986","journal-title":"Lancet"},{"key":"R15-22-20210208","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s001250051115","article-title":"The relation between QTc interval prolongation and diabetic complications. The EURODIAB IDDM Complication Study Group","volume":"42","author":"Veglio","year":"1999","journal-title":"Diabetologia"},{"key":"R16-22-20210208","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00004872-200201000-00003","article-title":"The neurohormonal history of essential hypertension: towards primary or tertiary aldosteronism?","volume":"20","author":"Lim","year":"2002","journal-title":"J Hypertens"},{"key":"R17-22-20210208","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/01.CIR.90.2.779","article-title":"Association between QT interval and coronary heart disease in middle-aged and elderly men. The Zupthen Study","volume":"90","author":"Dekker","year":"1994","journal-title":"Circulation"},{"key":"R18-22-20210208","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1161\/01.HYP.0000125230.46080.c6","article-title":"QRS duration and QT interval predict mortality in hypertensive patients with left ventricular hypertrophy. The losartan intervention for endopoint reduction in hypertension study","volume":"43","author":"Oikarinen","year":"2004","journal-title":"Hypertension"},{"key":"R19-22-20210208","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/hrt.61.3.274","article-title":"Electrocardiographic findings and frequency of arrhythmias in Bartter's syndrome","volume":"61","author":"Blomstrom-Lundqvist","year":"1989","journal-title":"Br Heart J"},{"key":"R20-22-20210208","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1440-1681.2005.04161.x","article-title":"Prolongation of the QT interval in primary aldosteronism","volume":"32","author":"Matsumura","year":"2005","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"R21-22-20210208","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1681\/ASN.V1061297","article-title":"QT dispersion in patients with end-stage renal failure and during hemodialysis","volume":"10","author":"Lorincz","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"R22-22-20210208","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1681\/ASN.V101160","article-title":"QT dispersion before and after hemodialysis","volume":"10","author":"Morris","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"R23-22-20210208","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1161\/01.HYP.28.5.791","article-title":"Left ventricular hypertension and QT dispersion in hypertension","volume":"28","author":"Mayet","year":"1996","journal-title":"Hypertension"},{"key":"R24-22-20210208","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1161\/01.HYP.28.1.16","article-title":"Dispersion of QT interval and autonomic modulation of heart rate in hypertensive men with and without left ventricular hypertrophy","volume":"28","author":"Perkiomaki","year":"1996","journal-title":"Hypertension"},{"key":"R25-22-20210208","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2174\/187152506775268776","article-title":"Mineralocorticoid receptor blockade in the protection of target organ damage","volume":"4","author":"Mulatero","year":"2006","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"R26-22-20210208","first-page":"659","article-title":"Two new culprits in cardiovascular disease: QT dispersion and aldosterone","volume":"9","author":"Struthers","year":"1995","journal-title":"J Hum Hypertens"},{"key":"R27-22-20210208","doi-asserted-by":"crossref","first-page":"K70","DOI":"10.1016\/S1520-765X(01)90009-4","article-title":"Spectrum of drugs prolonging QT interval and the incidence of torsades de pointes","volume":"3","author":"Darpo","year":"2001","journal-title":"Eur Heart J Suppl"},{"key":"R28-22-20210208","first-page":"63","article-title":"Hyperglycemia and QT interval: time for re-evaluation","volume":"14","author":"Marfella","year":"2001","journal-title":"Diabetes Nutr Metab"},{"key":"R29-22-20210208","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/S0735-1097(01)01243-8","article-title":"Circadian variation in the effect of aldosterone blockade on heart rate variability and QT dispersion in congestive heart failure","volume":"37","author":"Yee","year":"2001","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004872-200612000-00022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T15:47:18Z","timestamp":1786031238000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004872-200612000-00022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.hjh.0000251908.93298.a0","relation":{},"ISSN":["0263-6352"],"issn-type":[{"value":"0263-6352","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}